Michael A. Letavic

Pharmacological characterization of a novel centrally permeable <scp>P2X7</scp> receptor antagonist: <scp>JNJ</scp>‐47965567

Anindya Bhattacharya, Qi Wang, Hong Ao et al. · British Journal of Pharmacology · 2013 · 191 citations · Full text

Transient P2X7 Receptor Antagonism Produces Lasting Reductions in Spontaneous Seizures and Gliosis in Experimental Temporal Lobe Epilepsy

Alba Jimenez‐Pacheco, Miguel Díaz‐Hernández, Marina Arribas-Blázquez et al. · Journal of Neuroscience · 2016 · 162 citations · Full text

Histamine H3 receptor antagonists: From target identification to drug leads

Pascal Bonaventure, Michael A. Letavic, Christine Dugovic et al. · Biochemical Pharmacology · 2006 · 134 citations

Drug Target, Allergy, Biochemistry +8

microRNA targeting of the P2X7 purinoceptor opposes a contralateral epileptogenic focus in the hippocampus

Eva M. Jiménez‐Mateos, Marina Arribas-Blázquez, Amaya Sanz‐Rodriguez et al. · Scientific Reports · 2015 · 108 citations · Full text

Enantioselective Total Synthesis of Gracilins B and C Using Catalytic Asymmetric Diels-Alder Methodology

E. J. Corey, Michael A. Letavic · Journal of the American Chemical Society · 1995 · 99 citations

Combinatorial Chemistry, Asymmetric Catalysis, Engineering +15